awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q49307383-2F37BEA6-4B8D-4A78-A806-B0E6B114B297
Q49307383-2F37BEA6-4B8D-4A78-A806-B0E6B114B297
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49307383-2F37BEA6-4B8D-4A78-A806-B0E6B114B297
Real-world usage and clinical outcomes of alectinib among post-crizotinib progression anaplastic lymphoma kinase positive non-small-cell lung cancer patients in the USA.
P2860
Q49307383-2F37BEA6-4B8D-4A78-A806-B0E6B114B297
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49307383-2F37BEA6-4B8D-4A78-A806-B0E6B114B297
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f11ea6048c0aa3c094a3a17439985492c50b6ad7
P2860
ALK inhibitors: what is the best way to treat patients with ALK+ non-small-cell lung cancer?